Psynary
📊 CLINICAL EVIDENCE

Up to 76% Remission in 90 Days

Psynary accelerates depression recovery through evidence-based treatment optimization.

76%
Remission Rate
Within 90 Days
Tokyo Clinic Re-audit76%
Overall Remission71%
OptiMA1 Dataset44%

Why Remission Matters

True recovery requires complete remission, not just partial improvement.

Complete Recovery Goal

Remission, not partial response, is the true goal in depression treatment.

Prevents Relapse

Residual symptoms strongly predict relapse and long-term disability.

Earlier Achievement

Psynary enables earlier, more reliable remission compared to standard care.

Clinical Evidence

Proven results across multiple clinical studies and real-world implementations.

📊 Key Findings

Tokyo Clinic Re-audit
76%
remission within 90 days
76%
Overall Remission Rate
71%
97% in patients completing full optimization
71%
Japan + New Zealand OptiMA1
44%
larger dataset remission
44%

Clinical Studies Comparison

Tokyo Clinic Re-audit (2018)

76%

Within 90 days - Highest recorded remission rate

Tokyo Clinic Audit (2017)

71%

97% in patients completing full optimization

OptiMA1 (Japan + NZ)

44%

Larger multi-national dataset

STAR*D Trial (Standard Care)

37%

Largest depression trial baseline

Clinical Impact

Accelerated remission delivers measurable benefits to patients and healthcare systems.

Faster Recovery

Faster remission improves long-term recovery outcomes and reduces relapse risk.

Reduced Costs

Optimized care reduces indirect costs of depression through faster return to function.

Clinical Trial Quality

Delivers outcomes comparable to STAR*D trials — but in less than half the time.

Time to Remission Comparison

Standard Care
180+
days to remission
Psynary Optimization
90
days to remission

Experience 76% Remission Rates

Join leading clinicians who trust Psynary to deliver superior patient outcomes through evidence-based optimization.